Gene G. Kinney's Insider Trades & SAST Disclosures

Gene G. Kinney's most recent trade in Prothena Corporation plc was a trade of 520,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2026.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Prothena Corporation plc
Gene G. Kinney Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 520,000 520,000 - - Stock Option (Right to Buy)
Prothena Corporation plc
Gene G. Kinney Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 140,000 152,793 (0%) 0% 0 Ordinary Shares, par value $0.01 per share
Prothena Corporation plc
Gene G. Kinney Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2025 375,000 375,000 - - Stock Option (Right to Buy)
Prothena Corporation plc
Kinney Gene G. President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 307,000 307,000 - - Stock Option (Right to Buy)
Prothena Corporation plc
Gene G. Kinney President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.81 per share. 17 May 2023 45,000 57,793 (0%) 0% 29.8 1,341,450 Ordinary Shares, par value $0.01 per share
Prothena Corporation plc
Gene G. Kinney President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 45,000 0 - - Stock Option (Right to Buy)
Prothena Corporation plc
Gene G. Kinney President and CEO Sale of securities on an exchange or to another person at price $ 73.60 per share. 17 May 2023 19,864 27,727 (0%) 0% 73.6 1,462,070 Ordinary Shares, par value $0.01 per share
Prothena Corporation plc
Gene G. Kinney President and CEO Sale of securities on an exchange or to another person at price $ 74.49 per share. 17 May 2023 14,934 12,793 (0%) 0% 74.5 1,112,501 Ordinary Shares, par value $0.01 per share
Prothena Corporation plc
Gene G. Kinney President and CEO Sale of securities on an exchange or to another person at price $ 72.70 per share. 17 May 2023 10,202 47,591 (0%) 0% 72.7 741,721 Ordinary Shares, par value $0.01 per share
Prothena Corporation plc
Gene G. Kinney President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 155,000 155,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades